CXCL11 and hyperinsulinemic hypoglycemia, familial, 4: The authors found that a mixture of BR1 and BR2 antagonists prevent totally the permeabilizing effect caused by C1-inhibitor deficiency in patients’ plasma samples collected during attacks [24].